AT1 0.00% 2.7¢ atomo diagnostics limited

Yep !! the Annual Report and the June quarterly will demonstrate...

  1. 187 Posts.
    lightbulb Created with Sketch. 141
    Yep !! the Annual Report and the June quarterly will demonstrate the revenue (cash receipts) growth from the NG Biotech orders. I do believe that a significant problem that plagues the share price is that there hasn't been a revenue update. last revenue figures are for half year ending 31st December 2019. It is currently May and the market has not been notified of the revenue earned during the March quarterly and April. It will just be a matter of patience.
    Last edited by Delcos66: 12/05/20
 
watchlist Created with Sketch. Add AT1 (ASX) to my watchlist
(20min delay)
Last
2.7¢
Change
0.000(0.00%)
Mkt cap ! $17.25M
Open High Low Value Volume
2.8¢ 2.9¢ 2.7¢ $10.03K 365.9K

Buyers (Bids)

No. Vol. Price($)
7 668702 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 11840 2
View Market Depth
Last trade - 16.10pm 24/06/2024 (20 minute delay) ?
AT1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.